Skip to Main Content

Paper Details

Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial.
Nature Medicine
41
2022
1273, B.1.617, COVID, SARS-, SARS-CoV, SARS-CoV-2, anti-spike IgG antibody, coronavirus disease, mRNA, mRNA-1273, memory B cell, participants, severe, severe acute respiratory syndrome coronavirus 2
Author NameAffiliation
David C MontefioriDepartment of Surgery and Duke Human Vaccine Institute
  • 1 - 1

Datasets

Release 1.2